Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 CAD | -4.22% | -7.72% | +440.48% |
05-13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
05-13 | Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+440.48% | 125M | |
+41.79% | 54.04B | |
+46.06% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- Medicenna Presents Preclinical Data on MDNA113 at the 38th Annual Meeting of the Society for Immunotherapy of Cancer